Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Circulation Research|May 1, 2004
Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1Sander Verheule, Toshiaki Sato, Thomas Everett, et al.Open Heart|July 13, 2019
Reducing radiation exposure during atrial fibrillation ablation using lectures to promote awarenessYosuke Miwa, Akiko Ueda, Michitsugu Komeda, et al.International Journal of Hematology|October 3, 2024
Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia veraKeita Kirito, Yuka Sugimoto, Akihiko Gotoh, et al.Frontiers in Pharmacology|October 10, 2024
Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2bAlbert Qin, Daoxiang Wu, Jason Liao, et al.International Heart Journal|November 23, 2018
Idiopathic Ventricular Arrhythmia Ablation Using Non-Fluoroscopic Catheter Visualization SystemAkiko Ueda, Kyoko Soejima, Yosuke Miwa, et al.Journal of Arrhythmia|October 13, 2017
Brain magnetic resonance imaging examination in a patient with non-magnetic resonance conditional pacemakerToshiko Nakai, Toshiaki Sato, Kyoko Soejima, et al.Future Oncology (London, England)|August 4, 2022
SURPASS-ET: phase III study of ropeginterferon alfa-2b versus anagrelide as second-line therapy in essential thrombocythemiaSrdan Verstovsek, Norio Komatsu, Harinder Gill, et al.European Heart Journal. Digital Health|January 23, 2025
Wristwatch pulse wave monitoring: assessing daily activity post-catheter ablation for atrial fibrillationNoriko Matsushita Nonoguchi, Kyoko Soejima, Yumi Katsume, et al.Journal of Arrhythmia|August 3, 2017
Elongated ascending aorta predicts a short distance between his-bundle potential recording site and coronary sinus ostiumYuichi Momose, Kyoko Soejima, Akiko Ueda, et al.International Journal of Hematology|March 9, 2026
Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter studyTadaaki Inano, Yuka Sugimoto, Kohshi Ohishi, et al.Pageof 12